search

Caribou Biosciences Inc (CRBU)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives Average Recommendation of "Moderate Buy" from Brokerages
Sep 19, 2026

Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives Average Recommendation of "Moderate Buy" from Brokerages

Caribou Biosciences (NASDAQ:CRBU) has received a consensus "Moderate Buy" rating from five analysts, with an average 12-month price target of $7.75, despite some recent downgrades. The company's shares opened at $1.30, near its 52-week low, and reported a quarterly loss of $0.24 per share, beating estimates, though revenue of $1.5 million fell short. Institutional investors hold 77.51% of CRBU stock, with several firms establishing new positions in recent quarters.
Company relevance
100.00%
Company sentiment
Neutral
Overall sentiment
Neutral